StratDeckDHR

Danaher Corporation

DHR✓
Share

Healthcare · Diagnostics & Research · United States

Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally.

Price203.25USD
1D+1.55%
Market cap143B
AnalystsStrong buy23
Next earnings20 Oct
Loading chart…

Trade ideas

DHR isn't in any strategy's Top Picks or Good Opportunities today.

Analysts

ConsensusStrong buy23
Mean score1.50
Mean target229.09+12.71%
Target range195.00–310.00

Value vs sector peers

#20 of 26 in HealthcareWeakest in sector32
  • Fwd P/E21.916
  • P/B2.777
  • Yield0.8%17
  • P/E36.321
  • Rev growth+5.5%28

Nearest in Healthcare

  1. #18GILDGilead Sciences, Inc.Paying up for quality38
  2. #19MRKMerck & Co., Inc.Weakest in sector33
  3. #20DHRDanaher CorporationWeakest in sector32
  4. #21MCKMcKesson CorporationPaying up for quality29

Fundamentals

P/E36.3
Forward P/E21.9
Price / book2.72
Dividend yield0.80%
Beta0.81
52-week range160.93–242.8052/100
ADV (USD)683M
Relative volume1.2
10d avg volume3.12M
Revenue growth+5.50%
EPS growth+59.70%

Performance

1D+1.55%
7D-2.12%
1M+0.40%
3M+12.46%
6M+6.64%
YTD-10.84%

In the briefing and the feed

Briefing for 11 Sept

Neither the briefing nor the research feed has named DHR.

Catalysts

Next earnings: 20 Oct

Trade idea history

  • 10 SeptLong200.537Dpending2Wpending1Mpending

Get it by email

The board DHR sits on, in one five-minute email every weekday before the New York open and on Saturdays: market strength, the biggest movers, earnings coming up and the names sitting at their 200-day EMA.